Lyell Immunopharma (LYEL) Short Interest
Nasdaq • LYEL • US55083R2031
As of Oct 23, 2026, ORTEX estimated 14.4% of free float sold short, 8.7 days to cover, cost to borrow 0.64%. Sign up for live short interest data.
Nasdaq • LYEL • US55083R2031
As of Oct 23, 2026, ORTEX estimated 14.4% of free float sold short, 8.7 days to cover, cost to borrow 0.64%. Sign up for live short interest data.
This page tracks how heavily Lyell Immunopharma (Nasdaq:LYEL) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Lyell Immunopharma (Nasdaq: LYEL) has a market capitalization of $379.11M. Last close $15.42 (as of 2026-11-10); 52-week range $7.20 to $45.00. ORTEX data as of 2026-10-23: short interest was 14.36% of free float, 8.7 days to cover and the average cost to borrow was 0.64%. Sign up for live short interest data.